AcuCall Revenue and Competitors
Estimated Revenue & Valuation
- AcuCall's estimated annual revenue is currently $870k per year.
- AcuCall's estimated revenue per employee is $87,000
Employee Data
- AcuCall has 10 Employees.
AcuCall's People
Name | Title | Email/Phone |
---|---|---|
1 | Founder - CEO & CTO | Reveal Email/Phone |
AcuCall Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $74.4M | 208 | 16% | N/A | $500M |
#2 | $2970M | 19 | 27% | $700M | $1.7B |
#3 | $1840M | 6608 | N/A | N/A | $16.7B |
#4 | $25.4M | 165 | -19% | N/A | N/A |
#5 | $68.6M | 192 | N/A | N/A | N/A |
#6 | $4.6M | 20 | N/A | N/A | N/A |
#7 | $127.6M | 314 | 3% | N/A | N/A |
#8 | $9.4M | 36 | N/A | N/A | N/A |
#9 | $55.5M | 317 | 14% | $73.2M | N/A |
#10 | $10.1M | 41 | -2% | $19.9M | N/A |
#11 | $7.3M | 63 | -2% | N/A | N/A |
#12 | $154.7M | 762 | N/A | N/A | N/A |
#13 | $13.7M | 98 | 69% | $11M | N/A |
#14 | $34.8M | 226 | 7% | N/A | N/A |
#15 | $9.4M | 72 | N/A | N/A | N/A |
#16 | N/A | 60 | N/A | N/A | N/A |
#17 | $5.3M | 46 | N/A | N/A | N/A |
#18 | $438.2M | 963 | N/A | N/A | N/A |
#19 | $64.7M | 181 | 1% | N/A | N/A |
#20 | $4.6M | 20 | N/A | N/A | N/A |
What Is AcuCall?
N/A
Total Funding
10
Number of Employees
$870k
Revenue (est)
N/A
Employee Growth %
N/A
Valuation
N/A
Accelerator
AcuCall News
2022-03-22 - Nayzilam (Midazolam) Nasal: Uses, Side Effects, Dosages
Other seizure cluster medications include: Diastat and AcuDial (diazepam rectal gel); Valtoco (diazepam nasal spray); Ativan (oral lorazepam).
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1M | 12 | -14% | N/A |
#2 | $2.1M | 13 | 0% | N/A |
#3 | $1.3M | 14 | 0% | N/A |
#4 | $4M | 21 | -74% | N/A |
#5 | $3.2M | 21 | N/A | N/A |